Cite
Patient‐derived Immunocompetent Tumor Organoids: A Platform for Chemotherapy Evaluation in the Context of T‐cell Recognition**.
MLA
Zhao, Zihan, et al. “Patient‐derived Immunocompetent Tumor Organoids: A Platform for Chemotherapy Evaluation in the Context of T‐cell Recognition**.” Angewandte Chemie International Edition, vol. 63, no. 9, Feb. 2024, pp. 1–11. EBSCOhost, https://doi.org/10.1002/anie.202317613.
APA
Zhao, Z., Zhang, S., Jiang, N., Zhu, W., Song, D., Liu, S., Yu, W., Bai, Y., Zhang, Y., Wang, X., Zhong, X., Guo, H., Guo, Z., Yang, R., & Li, J. P. (2024). Patient‐derived Immunocompetent Tumor Organoids: A Platform for Chemotherapy Evaluation in the Context of T‐cell Recognition**. Angewandte Chemie International Edition, 63(9), 1–11. https://doi.org/10.1002/anie.202317613
Chicago
Zhao, Zihan, Shuren Zhang, Ning Jiang, Wenjie Zhu, Dongfan Song, Siyang Liu, Wenhao Yu, et al. 2024. “Patient‐derived Immunocompetent Tumor Organoids: A Platform for Chemotherapy Evaluation in the Context of T‐cell Recognition**.” Angewandte Chemie International Edition 63 (9): 1–11. doi:10.1002/anie.202317613.